QED is delighted to announce that it has been chosen to work on a phase II Gynaecology trial for a long-term Sponsor. The study is anticipated to run for approximately 16 months and will include sites in Belgium, Spain and Czech Republic. The study will investigate a new treatment aimed at improving the implantation of embryos in IVF treatment.
Thomas Ogorka, QED CEO commented “We are extremely happy that this Sponsor, with whom we have been collaborating on numerous trials over the past several years, continues to have confidence in our ability to deliver their studies. We remain committed to our partnership with this Sponsor and are confident of another successful outcome on this project”.